The table below shows AMICUS THERAPEUTICS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$33.15M
-$33.89M
-$69.09M
-$166.57M
-$202.49M
-$233.29M
Capital expenditure
$3.30M
$3.55M
$7.44M
$3.77M
$3.88M
$3.23M
Investing cash flow
-$46.43M
-$560.00K
$98.06M
$92.32M
$78.76M
-$13.58M
Dividends paid
-
-
-
-
-
FOLD operating cash flow (10-K history)
AMICUS THERAPEUTICS, INC. reported operating cash flow of $33.15M for fiscal year 2025. That is up 197.8% from -$33.89M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$150.15M (FY 2016) to $33.15M. Figures come from the company's audited annual reports as filed with the SEC.
